Back to search results

Study of Chronic Cardiovascular Conditions

This study is looking at how chronic (long-lasting) heart and blood vessel conditions, like heart failure, aortic stenosis (a heart valve problem), and high blood pressure, naturally progress over time. Researchers will collect information about your body's functions to better understand these conditions. There are no specific treatments or interventions being tested in this study. To join, you must be at least 18 years old, able to understand study information and give consent, and have a diagnosis of a qualifying cardiovascular disease. The study aims to understand how your health status changes over 90-day cycles. The current recruitment status is unclear.

Study design
This is an observational study, meaning researchers will watch and collect information without giving any specific treatments. It plans to include about 5000 participants.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your clinical status will be assessed at the beginning of the study and then every 90 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07420907

Study of the Progression of Chronic Cardiovascular Conditions

Recruiting
Not specifiedAges 18+Observational
Prolaio
~5,000 participants
Updated 2026-08-12 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Longitudinal Assessment of Clinical Status
Measured over Baseline through each 90-day cycle
+3 more outcomes measured

Conditions

Cardiovascular Disease (CVD)
Heart Failure
Aortic Stenosis
Aortic Stenosis Disease
Hypertension
Hypertension (HTN)
Hypertrophic Cardiomyopathy Patients
Hypertrophic Cardiomyopathy Without Obstruction
Hypertrophic Cardiomyopathy, Obstructive
Dilated Cardiomyopathy (DCM)
Dilated Cardiomyopathy
Dilated Cardiomyopathy, Familial

Explore related trials

Aortic Valve StenosisCardiovascular DisorderDilated CardiomyopathyHeart FailureHypertensionHypertrophic Cardiomyopathy

Where it's being run

1 sites across 1 states
Illinois1

Who to contact

Study Team OCORO Study
[email protected]
1-855-869-9054
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

18 years of age and older
Ability to understand study assessments and give informed consent to data collection
Ability to comply with the study protocol
Ability to understand and respond to instructions in English
Has diagnosis of qualifying Cardiovascular Disease(s), including but not limited to: HF, AS, HCM, HTN, DCM, etc. Additional CVD may be included at discretion of the investigators.
Resides in the United States

Exclusion

Allergy to adhesive used in biosensor patch
Life-threatening disease process outside of area under study, such as actively treated cancer or being actively considered for organ pre-transplant (such as hepatic failure; end-stage renal disease).
Severe CVD defined by hospital admission for cardiac diagnosis within 30 days of enrollment or documentation of NYHA functional class IV
\-- For participants who do not qualify due to this exclusion, and have not been hospitalized within 30 days of enrollment, they may reapply to enroll in the study
Self-reported weight of 400 pounds or greater

What this trial measures

  • Longitudinal Assessment of Clinical StatusBaseline through each 90-day cycle

    Measured by Heart Rate (beats per minute)

  • Longitudinal Assessment of Clinical StatusBaseline through each 90-day cycle

    Heart Rate Variability (per millisecond)

  • Longitudinal Assessment of Clinical StatusBaseline through each 90-day cycle

    percentage of Atrial Fibrillation Burden (duration of time per day of demonstrated AF)

  • Longitudinal Assessment of Clinical StatusBaseline through each 90-day cycle

    Breaths per minute